Since 2017, Dr. Krieg has led a cutting-edge research laboratory at MUSC focused on understanding immune responses in cancer, autoimmune diseases, and neurodegenerative disorders.
JOHNS ISLAND, SC, October 29, 2024 /24-7PressRelease/ -- Carsten Krieg, PhD, has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Dr. Krieg is an internationally renowned expert in translational immunology, immunotherapy, and high-dimensional single-cell technology. He serves as an Assistant Professor at the Medical University of South Carolina (MUSC) within the Departments of Pathology & Laboratory Medicine and Dermatology. He also holds the position of CEO at CellXAnalytics LLC, where he provides strategic consulting on clinical trial design, immunotherapy, and patient evaluation while developing advanced diagnostic tools and trial improvement strategies.
Since 2017, Dr. Krieg has led a cutting-edge research laboratory at MUSC focused on understanding immune responses in cancer, autoimmune diseases, and neurodegenerative disorders. His groundbreaking work in single-cell spatial analysis has transformed the understanding of disease progression at the cellular level. As Director of the Immune Monitoring and Diagnostic Core, he has pioneered the use of innovative technologies like single-cell RNA sequencing mass cytometry and imaging mass cytometry to advance immunological research.
In addition to his academic contributions, Dr. Krieg's leadership in the biotech sector is demonstrated through his role as CEO of CellXAnalytics LLC, where his expertise in single-cell analysis helps drive innovation for researchers and companies. His commitment to fostering excellence in science extends to his role as Faculty Senator for Basic Science at MUSC, underscoring his dedication to leadership, professionalism, and scientific collaboration.
Before his tenure at MUSC, Dr. Krieg was a University Research Priority Programs fellow at the Institute of Experimental Immunology at the University of Zurich, Switzerland, where he made key contributions to cancer immunotherapy. Earlier in his career, he gained crucial expertise in immunology and immunotherapy at The Scripps Research Institute and refined his skills in cytokine-driven therapies at Lausanne University Hospital, Switzerland.
Dr. Krieg earned a PhD in Virology and Infectious Diseases from Saarland University and holds a Diploma in Biology, Biochemistry, and Virology from the Bernhard Nocht Institute for Tropical Medicine at the University of Hamburg. His strong academic foundation has been essential to his success in both research and entrepreneurial ventures.
Throughout his distinguished career, Dr. Krieg has received numerous accolades, including American Association of Immunologists (AAI) Early Career Awards in 2013 and 2021-2024. He is also a German Academic Scholar and an active member of esteemed organizations such as the American Association of Immunologists, the German Society for Immunology, the Society for Immunotherapy of Cancer, and the American Association for Cancer Research.
Dr. Krieg is committed to fostering diversity and inclusion in the sciences. He mentors individuals from underrepresented backgrounds, helping them develop careers in immunology and research. His dedication to mentorship and opportunity underscores his commitment to making science more accessible to all.
Born in Hamburg, Dr. Krieg enjoys spending time outside his professional life hiking, traveling, mountaineering, swimming, gardening, and exploring new cuisines with his wife. He attributes his success to collaborative efforts with like-minded colleagues and his unwavering positive mindset, which continues to fuel his drive for innovation and leadership in immunology. Looking ahead, Dr. Krieg is focused on advancing his research to develop new therapeutic approaches for cancer, autoimmune diseases, and neurodegenerative conditions. He also seeks to raise awareness of the tools and resources that can improve lives and serve as inspiration for immigrants like himself.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.
# # #